We observed no strong positive correlations for lung adenocarcinoma, providing evidence that the transcriptional effects of mutations in KRAS, EGFR, MET, NTRK1, and PIK3CA are distinct from each other (Fig. 5). This evidence concerns the gene PIK3CA and lung adenocarcinoma.